• 1
    Worthley LI, Guerin M, Pain RW. For calculating osmolality, the simplest formula is best. Anaesthesia and Intensive Care 1987; 15: 199202.
  • 2
    Bhagat CI, Garcia-Webb P, Fletcher E, Beilby JP. Calculated vs measured plasma osmolalities revisited. Clinical Chemistry 1984; 30: 17035.
  • 3
    Ammar KA, Heckerling PS. Ethylene glycol poisoning with a normal anion gap caused by concurrent ethanol ingestion: importance of the osmolal gap. American Journal of Kidney Disease 1996; 27: 1303.
  • 4
    Hovda KE, Hunderi OH, Rudberg N, Froyshov S, Jacobsen D. Anion and osmolal gaps in the diagnosis of methanol poisoning: clinical study in 28 patients. Intensive Care Medicine 2004; 30: 18426.
  • 5
    DuBose TD. Acidosis and alkalosis. In: FauciAS, eds. Harrison's Principles of Internal Medicine, 14th edn. New York: McGraw-Hill, 1988: 27786.
  • 6
    Worthley LIG. Acid-base balance and disorders. In: BerstenAD, SoniN, OhTE, eds. Oh's Intensive Care Manual, 5th edn. London: Butterworth Heinemann, 2003: 87383.
  • 7
    Rocktaeschel J, Morimatsu H, Uchino S, et al. Acid-base status of critically ill patients with acute renal failure: analysis based on Stewart-Figge methodology. Critical Care 2003; 7: R606.
  • 8
    Story DA, Tosilini A, Bellomo R, LeBlanc M, Braqantini L, Ronco C. Plasma acid-base changes in chronic renal failure: a Stewart approach. International Journal of Artificial Organs 2005; 28: 9615.
  • 9
    Kirschbaum B. Effect of hemodialysis on the hypersulphatemia of chronic renal failure. American Society for Artificial Organs Journal 1998; 44: 3148.
  • 10
    Cohen RD. Roles of the liver and kidney in acid-base regulation and its disorders. British Journal of Anaesthesia 1991; 67: 15464.
  • 11
    Atkinson DE, Camien MN. The role of urea synthesis in the removal of metabolic bicarbonate and the regulation of blood pH. Current Topics in Cellular Regulation 1982; 21: 261302.
  • 12
    Mizock BA, Falk JL. Lactic acidosis in critical illness. Critical Care Medicine 1992; 20: 8093.
  • 13
    Fall PJ, Szerlip HM. Lactic acidosis: from sour milk to septic shock. Journal of Intensive Care Medicine 2005; 20: 25571.
  • 14
    Morgan TJ, Venkatesh B, Hall J. Crystalloid strong ion difference determines metabolic acid-base change during in vitro haemodilution. Critical Care Medicine 2002; 30: 15760.
  • 15
    Morgan TJ, Venkatesh B, Hall J. Crystalloid strong ion difference determines metabolic acid-base change during acute normovolaemic haemodilution. Intensive Care Medicine 2004; 30: 14327.
  • 16
    Yudkin J, Cohen RD. The contribution of the kidney to the removal of lactic acid load under normal and acidotic conditions in the conscious rat. Clinical Science and Molecular Medicine 1975; 48: 12131.
  • 17
    Bellomo R. Bench-to-bedside review: Lactate and the kidney. Critical Care 2002; 6: 3226.
  • 18
    Hohmann B, Frohnert PP, Kinne R, Baumann K. Proximal tubular lactate transport in rat kidney: a micropuncture study. Kidney International 1974; 261: 511.
  • 19
    McKelvie Lindiger MI, Heigenhauser GJ, Sutton JR, Jones NL. Renal responses to exercise-induced lactic acidosis. American Journal of Physiology 1989; 257: R1028.
  • 20
    Leal-Pinto E, Park HC, King F, MacLeod M, Pitts RF. Metabolism of lactate by the intact functioning kidney of the dog. American Journal of Physiology 1973; 224: 14637.
  • 21
    Nolph KD, Twardowski R, Khanna R, et al. Tidal peritoneal dialysis with racemic or 1-lactate solutions. Peritoneal Dialysis International 1990; 10: 1614.
  • 22
    White SA, Goldhill DR. Is Hartmann's the solution? Anaesthesia 1997; 52: 4227.
  • 23
    Hartmann AF, Senn MJE. Studies in the metabolism of sodium r-lactate. I. Response of normal human subjects to the intravenous injection of sodium r-lactate. Journal of Clinical Investigation 1932; 11: 32735.
  • 24
    Murray MJ, Gonze MD, Nowak LR, Cobb CF. Serum D(–) lactate levels as an aid to diagnosing intestinal ischaemia. American Journal of Surgery 1994; 167: 5758.
  • 25
    Smith SM, Eng RHK, Buccini F. Use of d-lactic acid measurements in the diagnosis of bacterial infections. Journal of Infectious Diseases 1986; 154: 65864.
  • 26
    De Keijzer MH, Brandts RW, Brans PGW. Evaluation of a biosensor for the measurement of lactate in whole blood. Clinical Biochemistry 1999; 32: 10912.
  • 27
    Morgan TJ, Clark C, Clague A. Artifactual elevation of measured plasma l-lactate concentration in the presence of glycolate. Critical Care Medicine 1999; 27: 21779.
  • 28
    Woo MY, Greenway DC, Nadler SP, Cardinal P. Artifactual elevation of lactate in ethylene glycol poisoning. Journal of Emergency Medicine 2003; 25: 28993.
  • 29
    Cohen RD, Simpson R. Lactate metabolism. Anesthesiology 1975; 43: 66173.
  • 30
    Fink MP. Does tissue acidosis in sepsis indicate hypoperfusion? Intensive Care Medicine 1996; 22: 11446.
  • 31
    Hotchkiss RS, Karl IE. Reevaluation of the role of cellular hypoxia and bioenergetic failure in sepsis. Journal of the American Medical Association 1992; 267: 150310.
  • 32
    Bellomo R, Kellum JA, Pinsky MR. Visceral lactate fluxes during early endotoxaemia in the dog. Chest 1996; 110: 198204.
  • 33
    Curtis SE, Cain SM. Regional and systemic oxygen delivery/uptake relations in hyperdynamic, endotoxin-treated dogs. American Review of Respiratory Disease 1992; 145: 34854.
  • 34
    Cain SM, Curtis SE. Systematic and regional oxygen uptake and delivery and lactate flux in endotoxic dogs infused with dopexamine. Critical Care Medicine 1991; 19: 155260.
  • 35
    Due V, Bonde J, Espersen K, Jensen TH, Perner A. Lactic acidosis in the rectal lumen of patients with septic shock measured by luminal equilibrium analysis. British Journal of Anaesthesia 2002; 89: 91922.
  • 36
    Perner A, Jorgensen VL, Poulsen TD, Steinbruchel D, Larsen B, Andersen LW. Increased concentrations of l-lactate in the rectal lumen in patients undergoing cardiopulmonary bypass. British Journal of Anaesthesia 2005; 95: 7648.
  • 37
    Germann R, Haisjackl M, Schwarz B, et al. Inotropic treatment and intestinal mucosal tissue oxygenation in a model of porcine endotoxaemia. Critical Care Medicine 1997; 25: 11917.
  • 38
    Salak N, Pakj W, Knotzer H, et al. Effects of epinephrine on intestinal oxygen supply and mucosal tissue oxygen tension in pigs. Critical Care Medicine 2001; 29: 36773.
  • 39
    Howard JJ, Fischer JE. Epinephrine and gut lactate production. Critical Care Medicine 2001; 29: 4545.
  • 40
    Kellum JA, Kramer DJ, Lee KH, et al. Release of lactate by the lung in acute lung injury. Chest 1997; 111: 13015.
  • 41
    DeBacker D, Creuetr J, Zhang H, et al. Lactate production by the lungs in acute lung injury. American Journal of Respiratory and Critical Care Medicine 1997; 156: 1099104.
  • 42
    Brown SD, Clark C, Guttierez G. Pulmonary lactate release in patients with sepsis and the adult respiratory distress syndrome. Journal of Critical Care 1996; 11: 28.
  • 43
    Guttierez G, Chawla LS, Seneff MG, Katz NM, Zia H. Lactate concentration gradient from right atrium to pulmonary artery. Critical Care 2005; 9: R4259.
  • 44
    Rivers E, Nguyen B, Havstad S, et al. on behalf of EGDT Collaborative Group. Early goal directed therapy in the treatment of severe sepsis and septic shock. New England Journal of Medicine 2001; 345: 136877.
  • 45
    Otero RM. Early goal directed therapy in severe sepsis and septic shock revisited: concepts, controversies and contemporary findings. Chest 2006; 130: 157995.
  • 46
    Levraut J, Ichai C, Petit I, Ciebiera JP, Perus O, Grimaud D. Low exogenous lactate clearance as an early predictor of mortality in normolactataemic critically ill septic patients. Critical Care Medicine 2003; 31: 70510.
  • 47
    Nguyen HB, Rivers EP, Knoblich BP, et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Critical Care Medicine 2004; 32: 163742.
  • 48
    James JH, Luchette FA, McCarter FD, Fischer JE. Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis. Lancet 1999; 354: 5058.
  • 49
    McCarter FD, Nierman SR, James JH, et al. Role of skeletal muscle Na+ K+ ATPase activity in increased lactate production in sub-acute sepsis. Life Sciences 2002; 70: 18758.
  • 50
    McCarter FD, James JH, Luchetter FA, et al. Adrenergic blockade reduces skeletal muscle glycolysis and Na(+), K(+) ATPase activity during haemorrhage. Journal of Surgical Research 2001; 99: 23544.
  • 51
    Luchette FA, Friend LA, Brown CC, Upputuri RK, James JH. Increased skeletal muscle Na+ K+ ATPase activity as a cause of increased lactate production after haemorrhagic shock. Journal of Trauma 1998; 44: 796801.
  • 52
    Luchette FA, Jenkins WA, Friend LA, et al. Hypoxia is not the sole cause of lactate production during shock. Journal of Trauma 2002; 53: 8078.
  • 53
    Levy B, Gibot S, Franck P, Cravoisy A, Bollaert PE. Relation between muscle Na+K+ ATPase activity and raised lactate concentrations in septic shock: a prospective study. Lancet 2005; 365: 8715.
  • 54
    Phyphers B, Pierce T. Lactate physiology in health and disease. British Journal of Anaesthesia 2006; 6: 12832.
  • 55
    Kilpatrick-Smith L, Dean L, Erecinska M, et al. Cellular effects of endotoxin in vitro. II. Reversibility of endotoxin damage. Circulatory Shock 1983; 11: 10111.
  • 56
    Gore DC, Jahoor F, Hibbert JM, et al. Lactic acidosis during sepsis is related to increased pyruvate production, not deficits in tissue oxygen delivery. Annals of Surgery 1996; 224: 97102.
  • 57
    Levy B, Sadoune LO, Gelot AM, Bollaert PE, Nabet P, Larcan A. Evolution of lactate/pyruvate and arterial ketone body ratios in the early course of catecholamine-treated septic shock. Critical Care Medicine 2000; 28: 1149.
  • 58
    Willis N, Mogridge J. Indicators of histohypoxia. Acta Anaesthesiologica Scandinavica 1995; S107: 458.
  • 59
    Suistomaa M, Ruokonen E, Kari A, Takala J. Time-pattern of lactate and lactate to pyruvate ratio in the first 24 hours of intensive care emergency admissions. Shock 2000; 14: 812.
  • 60
    Shivalkar B, Engelmann I, Carp L, De Raedt H, Daelemans R. Shoshin syndrome: two case reports representing opposite ends of the same disease spectrum. Acta Cardiologica 1998; 53: 1959.
  • 61
    Corcoran TB, O'Hare B, Phelan D. Shoshin beriberi precipitated by intravenous glucose. Critical Care and Resuscitation 2002; 4: 314.
  • 62
    Quasim T, McMillan DC, Talwar D, St Vasilaki AJ, O'Reilly D, Kinsella J. The relationship between plasma and red-cell B vitamin concentrations in critically-ill patients. Clinical Nutrition 2005; 24: 95660.
  • 63
    Cruickshank AM, Telfer ABM, Shankin A. Thiamine in the critically ill. Intensive Care Medicine 1988; 4: 3847.
  • 64
    Day NP, Phu NH, Bethell DP, et al. The effects of dopamine and adrenaline infusions on acid-base balance and systemic haemodynamics in severe infection. Lancet 1996; 348: 21923.
  • 65
    James JH, Wagner KR, King JK, et al. Stimulation of both aerobic glycolysis and Na+K+ATPase activity in skeletal muscle by epinephrine or amylin. American Journal of Physiology 1999; E277: 17686.
  • 66
    Thomas S, Fell DA. A control analysis extrapolation of the role of ATP utilization in glycolytic-flux control and glycolytic-metabolite-concentration regulation. European Journal of Biochemistry 1998; 258: 95667.
  • 67
    Irving MH. The sympatho-adrenal factor in haemorrhagic shock. Annals of the Royal College of Surgeons of England 1968; 42: 36786.
  • 68
    UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352: 85465.
  • 69
    Galea M, Jelacin N, Bramaham K, White I. Severe lactic acidosis and rhabdomyolysis following metformin and ramipril overdose. British Journal of Anaesthesia 2007; 98: 2135.
  • 70
    Brown JB, Pedula MS, Barzilay J, et al. Lactic acidosis rates in type 2 diabetes. Diabetes Care 1998; 21: 165963.
  • 71
    Honda M, Oka S. Current therapy for human immunodeficiency virus infection and acquired immunodeficiency syndrome. International Journal of Haematology 2006; 84: 1822.
  • 72
    Vasseur BG, Kawanishi H, Shah N, Anderson ML. Type B lactic acidosis: a rare complication of antiretroviral therapy after cardiac surgery. Annals of Thoracic Surgery 2002; 74: 12512.
  • 73
    Valero MA, Leon-Sanz M, Escobar I, Gomis P, Camara A de la, Moreno JM. Evaluation of nonglucose carbohydrates in parenteral nutrition for diabetic patients. European Journal of Clinical Nutrition 2001; 55: 11116.
  • 74
    Trepannier CA, Lessard MR, Brchu J, Turcotte G. Another feature of TURP syndrome: hyperglycaemia and lactic acidosis caused by massive absorption of sorbitol. British Journal of Anaesthesia 2001; 87: 3169.
  • 75
    Schlichtig R, Klions KD, Kramer DJ, et al. Hepatic dysoxia commences during O2 supply dependence. Journal of Applied Physiology 1992; 72: 1499505.
  • 76
    Kitabchi AE, Sacks HS, Young RT, et al. Diabetic ketoacidosis: reappraisal of therapeutic approach. Annual Review of Medicine 1979; 30: 33957.
  • 77
    Davidsson T, Lindergard B, Mansson W. Long-term metabolic and nutritional effects of urinary diversion. Urology 1995; 46: 8049.
  • 78
    Morgan TJ. Clinical Review. The meaning of acid-base abnormalities in the intensive care unit – effects of fluid administration. Critical Care 2005; 9: 20411.
  • 79
    Story DA. Hyperchloraemic acidosis: another misnomer? Critical Care and Resuscitation 2004; 6: 18892.
  • 80
    Kellum JA. Saline induced hyperchloraemic metabolic acidosis. Critical Care Medicine 2002; 30: 25961.
  • 81
    Scheingraber Rehm M, Semisch C, Finsterer U. Rapid saline infusion produces hyperchloraemic acidosis in patients undergoing gynecologic surgery. Anesthesiology 1999; 90: 126570.
  • 82
    Prough DS, Bidani A. Hyperchloraemic metabolic acidosis is a predictable consequence of intraoperative infusion of 0.9% saline. Anesthesiology 1999; 90: 12479.
  • 83
    McFarlane C, Lee AA. A comparison of plasmalyte 148 and 0.9% saline for intraoperative fluid replacement. Anaesthesia 1994; 49: 77981.
  • 84
    Williams EL, Hildebrand KL, McCormick SA, Bedel MJ. The effect of intravenous lactated Ringer's solution versus 0.9% sodium chloride solution on serum osmolality in human volunteers. Anesthesia and Analgesia 1999; 88: 9991003.
  • 85
    Waters JH, Miller LR, Clack S, Kim J. Cause of metabolic acidosis in prolonged surgery. Critical Care Medicine 1999; 27: 21426.
  • 86
    Mathes DD, Morell RC, Rohr MS. Dilutional acidosis: is it a real clinical entity? Anesthesiology 1997; 86: 5013.
  • 87
    Russo MA. Dilutional acidosis: a nonentity? Anesthesiology 1997; 87: 10101.
  • 88
    Hatherhill M, Salie S, Waggie Z, et al. Hyperchloraemic metabolic acidosis following open cardiac surgery. Archives of Disease in Childhood 2005; 90: 128892.
  • 89
    Wilkes NJ, Woolf R, Mutch M, Mallett SV, Peachey T, Stephens R, Mythen MG. The effects of balanced versus saline-based hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients. Anesthesia and Analgesia 2001; 93: 8116.
  • 90
    Almasri E, Song M, Kellum JA. Effects of hyperchloraemic acidosis on circulatng cytokines in experimental sepsis in rats: 506. Critical Care Medicine 2004; S32: A141.
  • 91
    The SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. New England Journal of Medicine 2004; 350: 224756.
  • 92
    The SAFE Study Investigators. The effects of saline or albumin resuscitation on acid-base status and serum electrolytes. Critical Care Medicine 2006; 34: 28917.
  • 93
    Kellum JA. Fluid resuscitation and hyperchloraemic acidosis in experimental sepsis: improved short term survival and acid base balance with Hextend compared with saline. Critical Care Medicine 2002; 30: 3005.
  • 94
    Story DA. Intravenous fluid administration and controversies in acid-base. Critical Care and Resuscitation 1999; 1: 1516.
  • 95
    Story DA, Morimatsu H, Bellomo R. Hyperchloraemic acidosis in the critically ill: one of the strong ion acidoses? Anesthesia and Analgesia 2006; 103: 1448.
  • 96
    Gunnerson KJ, Kellum JA. Acid-base and electrolyte analysis in critically ill patients. are we ready for the new millennium? Critical Care Medicine 2003; 9: 46873.
  • 97
    Liano F, Junco E, Pascual J, Madeiro R, Verde E. The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. The Madrid Acute Renal Failure Study Group. Kidney International 1998; 66: S1624.
  • 98
    Santos WJQ, Zanetta DMT, Pires AC, Lobo SMA, Lima EQ, Burdmann EA. Patients with ischaemic, mixed and nephrotoxic acute tubular necrosis in the intensive care unit – a homogeneous population? Critical Care 2006; 10: R68.
  • 99
    Bobelescu IA, Moe OW. Na+/H+ exchangers in regulation of acid-base balance. Seminars in Nephrology 2006; 26: 33444.
  • 100
    Margassery S, Bastani B. Life threatening hyperkalaemia and acidosis secondary to trimethoprim-sulfamethoxazole treatment. Journal of Nephrology 2001; 14: 4104.
  • 101
    Alappan R, Perazella MA, Buller GK. Hyperkalaemia in hospitalized patients treated with trimethoprim-sulfamethoxazole. Annals of Internal Medicine 1996; 124: 31620.
  • 102
    Lin SH, Kuo AA, Lin YF. Reversible voltage-dependent distal renal tubular acidosis in a patient receiving standard doses of trimethoprim-sulphamethoxazole. Nephrology, Dialysis, Transplantation 1997; 12: 10313.
  • 103
    Gattinoni L, Carlesso E, Cadringher P, Carioni P. Strong ion difference in urine: new perspectives in acid-base assessment. Critical Care 2006; 10: 137.
  • 104
    Carlisle EJ, Donnelly SM, Halperin ML. Renal tubular acidosis (RTA): recognize the ammonium defect and pHorget the urine pH. Pediatric Nephrology 1991; 5: 2428.
  • 105
    Day NPJ, Phu NH, Mai N, et al. The pathophysiologic and prognostic significance of acidosis in severe adult malaria. Critical Care Medicine 2000; 28: 183340.
  • 106
    Niwa T. Organic acids and the uremic syndrome: protein metabolite hypothesis in the progression of chronic renal failure. Seminars in Nephrology 1996; 16: 16782.
  • 107
    Kirschbaum B. Sulfate regulation: native kidney vs dialysis. International Journal of Artificial Organs 1999; 22: 5912.
  • 108
    Story DA, Tosolini A, Bellomo R, Leblanc M, Bragantini L, Ronco C. Plasma acid-base changes in chronic renal failure: a Stewart analysis. International Journal of Artificial Organs 2005; 28: 9615.
  • 109
    Moviat M, Van Haren F, Van Der Hoeven H. Conventional or physicochemical approach in intensive care unit patients with metabolic acidosis. Critical Care 2003; 7: R415.
  • 110
    Singh RN, Singh NC, Hutchinson J, Moses GC. Lower anion gap increases sensitivity in predicting elevated lactate. Clinical Intensive Care 1994; 5: 2214.
  • 111
    Dubin A, Menises MM, Masevicius FD, et al. Comparison of three different methods of evaluation of metabolic acid-base disorders. Critical Care Medicine 2007; 35: 126470.
  • 112
    Yucher NE, Fish JT, Smith HW, Wells JA. Propylene glycol associated renal toxicity from lorazepam infusion. Pharmacotherapy 2003; 23: 10949.
  • 113
    Hayman M, Seidl EC, Ali M, Malik K. Acute tubular necrosis associated with propylene glycol from concomitant administration of lorazepam and trimethoprim-sulfamethoxazole. Pharmacotherapy 2003; 23: 11904.
  • 114
    McConnel JR, Ong CS, McAllister JL, Gross TG. Propylene glycol toxicity following continuous etomidate infusion for the control of refractory cerebral edema. Neurosurgery 1996; 38: 2323.
  • 115
    Morris C, McAllister C. Etomidate for emergency anaesthesia: mad, bad and dangerous to know? Anaesthesia 2005; 60: 73740.
  • 116
    Corey HE. Stewart and beyond: new models of acid-base balance. Kidney International 2003; 64: 77787.
  • 117
    Logan G, Goli SA, McGonagle M, Byrd RP Jr, Roy TM. Thiamine deficiency as a cause of metabolic acidosis. Tennessee Medicine 2003; 96: 5535.
  • 118
    Kam PCA, Cardone D. Propofol infusion syndrome. Anaesthesia 2007; 62: 690701.
  • 119
    Ahlen K, Buckley CJ, Godale DB, Pulsford AH. The ‘propofol infusion syndrome’: the facts, their interpretation and implications for patient care. European Journal of Anaesthesiology 2006; 23: 9908.
  • 120
    Fudickar A, Bein A, Tonner PH. Propofol infusion syndrome in anaesthesia and intensive care medicine. Current Opinion in Anesthesiology 2006; 19: 40410.
  • 121
    Pitt JJ, Brown GK, Clift V, et al. Atypical pyroglutamic aciduria: a possible role of paracetamol. Journal of Inherited Metabolic Disease 1990; 13: 7556.
  • 122
    Croal BL, Glen AC, Kelly CJ, et al. Transient 5-oxoprolinuria (pyroglutamic aciduria) with systemic acidosis in an adult receiving antibiotic therapy. Clinical Chemistry 1998; 44: 33640.
  • 123
    Dempsey GA, Lyall HJ, Corke CF, et al. Pyroglutamic acidaemia: a cause of high anion gap acidosis. Critical Care Medicine 2000; 28: 18037.
  • 124
    Peter JV, Rogers N, Murty S, Gerace R, Mackay R, Peake SL. An unusual cause of severe metabolic acidosis. Medical Journal of Australia 2006; 185: 2235.
  • 125
    Dart RC, Kuffner EK, Rumack BH. Treatment of pain or fever with paracetamol (acetaminophen) in the alcoholic patient: a systematic review. American Journal of Theraputics 2000; 7: 1234.
  • 126
    Prescott LF. Therapeutic misadventure with paracetamol: fact or fiction? American Journal of Theraputics 2000; 7: 99114.
  • 127
    Grice AS, Peck TE. Multiple acyl-CoA dehydrogenase deficiency: a rare cause of acidosis with an increased anion gap. British Journal of Anaesthesia 2001; 86: 43741.
  • 128
    Vockley J. The changing face of disorders of fatty acid oxidation. Mayo Clinical Proceedings 1994; 69: 24957.
  • 129
    Rinaldo P, Matern D, Bennett MJ. Fatty acid oxidation disorders. Annual Review of Physiology 2002; 64: 477502.
  • 130
    Summar ML, Barr F, Dawling S, et al. Unmasked adult onset urea cycle disorders in the critical care setting. Critical Care Medicine 2005; 21 (Suppl.): S18.
  • 131
    Smith W, Kishani PS, Lee B, et al. Urea cycle disorders: clinical presentation outside the newborn period. Critical Care Clinics 2005; 21 (Suppl.): S917.
  • 132
    Steiner RD, Cederbaum SD. Laboratory evaluation of urea cycle disorders. Journal of Pediatrics 2001; 138 (Suppl.): S219.
  • 133
    Levraut J, Grimaud D. Treatment of metabolic acidosis. Current Opinion in Critical Care 2003; 9: 2605.
  • 134
    Adrogue HJ, Madias NE. Management of life-threatening acid-base disorders. New England Journal of Medicine 1998; 338: 2634.
  • 135
    Bonventre JV, Cheung JY. Effects of metabolic acidosis on viability of cells exposed to anoxia. American Journal of Physiology 1985; 249: C14959.
  • 136
    Wright G, Kingston MA, Ross IS. Role of metabolic acidosis on cardiac mechanical performance during severe acute hypoxia and reoxygenation is small and transient. Cardiovascular Research 1995; 29: 6115.
  • 137
    Villar J, Kacmarek RM, Perez-Mendez L. A high positive end-expiratory pressure, low tidal volume ventilatory strategy improves outcome in persistent acute respiratory distress syndrome: a randomized controlled trial. Critical Care Medicine 2006; 34: 13118.
  • 138
    Hickling KG, Henderson SJ, Jackson R. Low mortality associated with low volume pressure limited ventilation with permissive hyperapnia in severe adult respiratory distress syndrome. Intensive Care Medicine 1990; 16: 3727.
  • 139
    The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. New England Journal of Medicine 2000; 342: 13018.
  • 140
    Wendon J, Smithies M, Shepperd M, Bullen K, Tinker J, Bihari DJ. Continuous high volume venous-venous hemofiltration in acute renal failure. Intensive Care Medicne 1989; 15: 35863.
  • 141
    Groenveld AB, Kolkman JJ. Splanchnic tonometry: a review of physiology, methodology and clinical applications. Journal of Critical Care 1994; 9: 198210.
  • 142
    Cerny V, Cvachovec K. Gastric tonometry and intramusocal pH – theoretical principles and practical application. Physiology Research 2000; 49: 28997.
  • 143[accessed 23 April 2007].
  • 144
    Severinghaus JW. More RIpH. Journal of the American Medical Association 1992; 267: 20356.
  • 145
    Cusack RJ, Rhodes A, Lochead P, et al. The strong ion gap does not have prognostic value in critically ill patients in a mixed medical/surgical adult ICU. Intensive Care Medicine 2002; 28: 8649.
  • 146
    Rocktaeschel J, Morimatsu H, Uchino S, Bellomo R. Unmeasured anions in critically ill patients: can they predict mortality? Critical Care Medicine 2003; 31: 21316.
  • 147
    Martin M, Murray J, Berne T, Demetriades D. Diagnosis of acid-base derangements and mortality prediction in the trauma intensive care unit: the physicochemical approach. Journal of Trauma 2005; 58: 23843.
  • 148
    Martin MJ, FitzSullivan E, Salim A, Brown CV, Demetriades D, Long W. Discordance between lactate and base deficit in the surgical intensive care unit: which one do you trust? American Journal of Surgery 2006; 191: 62530.
  • 149
    Kellum JA, Kaplan LJ. Initial pH, base deficit, lactate, anion gap, strong ion difference and strong ion gap predict outcome from major vascular injury. Critical Care Medicine 2004; 32: 11204.
  • 150
    Rixen D, Raum M, Bouillon B, et al. Base deficit development and its prognostic significance in posttrauma critical illness: an analysis by the trauma registry of the Deutsche Gesellschaft fur Unfallchirugie. Shock 2001; 15: 839.
  • 151
    Friedman G, Berlot G, Kahn RJ, Vincent JL. Combined measurements of blood lactate concentrations and gastric intramucosal pH in patients with severe sepsis. Critical Care Medicine 1995; 23: 118493.
  • 152
    De Jaeger A, Proulx F, Yandza T, et al. Markers of cellular dysoxia during orthotopic liver transplantation in pigs. Intensive Care Medicine 1998; 24: 26875.
  • 153
    Kellum JA. Lactate and pHi: our continued search for markers of tissue distress. Critical Care Medicine 1998; 26: 17834.
  • 154
    Yatani A, Fujino T, Kinoshita K, Goto M. Excess lactate modulates ionic currents and tension components in frog atrial muscle. Journal of Molecular and Cell Cardiology 1981; 13: 14761.
  • 155
    Bangsbo J, Gollnick PD, Graham TE, et al. Anaerobic energy production and O2 deficit-debt relationship during exhaustive exercise in humans. Journal of Physiology 1990; 422: 53959.
  • 156
    Berger DS, Fellner SK, Robinson KA, Vlasica K, Godoy IE, Shroff SG. Disparate effects of three types of extracellular acidosis on left ventricular function. American Journal of Physiology 1999; 276: H58294.
  • 157
    Webster NR, Kulkarni V. Metabolic alkalosis in the critically ill. Critical Reviews in Clinical Laboratory Science 1999; 36: 497510.
  • 158
    Naka T, Belomo R. Bench-to bedside review: Treating acid-base abnormalities in the intensive care unit – the role of renal replacement therapy. Critical Care 2004; 8: 10814.
  • 159
    Kraut JA, Kurtz. Use of base in the treatment of acute severe organic acidosis by nephrologists and critical care physicians: results of an online survey. Clinical and Experimental Nephrology 2006; 10: 1117.
  • 160
    Arieff AI. Indications for use of bicarbonate in patients with metabolic acidosis. British Journal of Anaesthesia 1991; 67: 16577.
  • 161
    Gehlbach BK, Schmidt GA. Bench-to-bedside review. Treating acid-base abnormalities in the intensive care unit- the role of buffers. Critical Care 2004; 8: 25965.
  • 162
    Androgue HJ, Brensilver J, Cohen JJ, Madias NE. Influence of steady-state alterations in acid-base equilibrium on the fate of administered bicarbonate in the dog. Journal of Clinical Investigation 1983; 71: 86783.
  • 163
    Mark NH, Leung JM, Arieff AI, Mangano DT. Safety of low-dose bicarbonate therapy: a prospective, double-blind, randomised study. The study of Perioperative Ischemia (SPI) Research Group. Critical Care Medicine 1993; 21: 65965.
  • 164
    Levraut J, Giunti C, Ciebiera JP, et al. Initial effect of sodium bicarbonate in intracellular pH depends on the extracellular nonbicarbonate buffering capacity. Critical Care Medicine 2001; 29: 10339.
  • 165
    Levraut J, Garcia P, Giunti C, et al. The increase in CO2 production induced by NaHCO3 depends on blood albumin and hemoglobin concentrations. Intensive Care Medicine 2000; 26: 55864.
  • 166
    Goldsmith DJ, Forni LG, Hilton PJ. Bicarbonate therapy and intracellular acidosis. Clinical Science (London) 1997; 93: 5938.
  • 167
    Cooper DJ, Walley KR, Wiggs BR, Russell JA. Bicarbonate does not improve the hemodynamics in critically ill patients who have lactic acidosis. A prospective, controlled study. Annals of Internal Medicine 1990; 112: 4928.
  • 168
    Mathieu D, Neviere R, Billard V, Fleyfel M, Wattel F. Effects of bicarbonate therapy on hemodynamics and tissue oxygenation in patients with lactic acidosis: a prospective, controlled study. Critical Care Medicine 1991; 19: 13526.
  • 169
    Narins RG, Cohen JJ. Bicarbonate therapy for organic acidosis: the case for its continued use. Annals of Internal Medicine 1987; 106: 6158.
  • 170
    Hindman BJ. Sodium bicarbonate in the treatment of subtypes of acute lactic acidosis: physiologic considerations. Anesthesiology 1990; 72: 106476.
  • 171
    Vukmir RB, Katz L on behalf of the Sodium Bicarbonate Study Group. Sodium Bicarbonate improves outcomes in prolonged prehospital cardiac arrest. American Journal of Emergency Medicine 2006; 24: 15661.
  • 172
    Bradberry SM, Thancoody HK, Watt BE, Thomas SH, Vale JA. Management of the cardiovascular complications of tricyclic antidepressant poisoning: role of sodium bicarbonate. Toxicology Review 2005; 24: 1952004.
  • 173
  • 174
    Zhou FQ. Pyruvate in the correction of intracellular acidosis: a metabolic basis as a novel superior buffer. American Journal of Nephrology 2005; 25: 5563.
  • 175
    Leung JM, Landow L, Franks M, et al. Safety and efficacy of intravenous Carbicarb in patients undergoing surgery: comparison with sodium bicarbonate in the treatment of mild metabolic acidosis. Study of Perioperative Ischaemia (SPI) Research Group. Critical Care Medicine 1994; 22: 15409.
  • 176
    Bersin RM, Arieff AI. Improved haemodynamic function during hypoxia with Carbicarb, a new agent for the management of acidosis. Circulation 1988; 77: 22733.
  • 177
    Rehm M, Finsterer U. Treating intraoperative hyperchloremic acidosis with sodium bicarbonate or tris-hydroxymethyl aminomethane: a randomised prospective study. Anesthesia and Analgesia 2003; 96: 12018.
  • 178
    Hoste EA, Colpaert K, Vanholder RC, et al. Sodium bicarbonate versus THAM in ICU patients with mild metabolic acidosis. Journal of Nephrology 2005; 18: 3037.
  • 179
    Borkan SC. Extracorporeal therapies for acute intoxications. Critical Care Clinics 2002; 18: 393420.
  • 180
    Goodman JW, Goldfarb DS. The role of continuous renal replacement therapy in the treatment of poisoning. Seminars in Dialysis 2006; 19: 4027.
  • 181
    Feinfeld DA, Rosenburg JW, Winchester JF. Three controversial issues in extracorporeal toxin removal. Seminars in Dialysis 2006; 19: 35862.
  • 182
    De Broe ME, Bismuth C, De Groot G, et al. Haemoperfusion: a useful therapy for a severely poisoned patient? Human Toxicology 1986; 5: 114.
  • 183
    Kar PM, KellnerK, Ing TS, Leehey DJ. Combined high-efficiency hemodialysis and charcoal hemperfusion in severe N-acetylprocainamide intoxication. American Journal of Kidney Disease 1992; 20: 4036.
  • 184
    Higgins RM, Hearing S, Goldsmith BJ, Keevil B, Venning MC, Ackrill P. Severe theophylline poisoning: charcoal haemoperfusion or haemodialysis? Postgraduate Medical Journal 1995; 71: 2246.
  • 185
    Pond SM. Extracorporeal techniques in the treatment of poisoned patients. Medical Journal of Australia 1991; 154: 61722.
  • 186
    Megarbane BN, Borron SW, Baud FJ. Current recommendations for treatment of severe toxic alcohol poisonings. Intensive Care Medicine 2005; 31: 18995.
  • 187 %22fomepizole%22 [accessed 23 April 2007].
  • 188
    Swartz RD, Millman RP, Billi JE, et al. Epidemic methanol poisoning: clinical and biochemical analysis of a recent episode. Medicine (Baltimore) 1981; 60: 37382.
  • 189
    Hovda KE, Andersson KS, Urdal P, Jacobsen D. Methanol and formate kietics during treatment with fomepizole. Clinical Toxicology (Philadelphia, PA) 2005; 43: 2217.